Ajanta Pharma USA Inc. till date has received seventeen ANDA final approvals and two ANDA tentative approvals from US Food and Drug Administration (FDA).

Currently, thirteen ANDAs are under review with the FDA.

Ajanta is poised to submit over eight to twelve ANDAs annually, ensuring a strong, consistent pipeline to fuel growth.

For list of products click here